Lead
"Is it okay to give my child probiotic drinks?" "Does my baby need a vitamin D supplement?" "Herbal remedies are gentler, right — they must be safe?" Complementary therapies are widely considered, and the interest is understandable.
But the quality of evidence varies enormously across products and claims. Some things can reasonably be called effective. Others cannot be called ineffective — the studies simply aren't there. This article works through three categories using a consistent framework: what condition, how much effect, under what conditions — based on the current state of the evidence, honestly.
A Starting Premise: "Natural" Does Not Mean "Safe"
The assumption that natural-origin products carry no side effects is not accurate. Anything administered to the body has the potential to affect it. The Paracelsian principle — that the dose determines the poison — applies to complementary therapies as much as to pharmaceuticals.
And "no evidence of effect" is not the same as "evidence of no effect." Some areas simply haven't been adequately studied. This article sorts claims into three categories: evidence of benefit, weak rationale, and requires caution.
Probiotics
Where the Evidence Is Strongest: Acute Infectious Diarrhea
The most consistent body of evidence for probiotics in children applies to shortening the duration of acute infectious diarrhea.
A 2013 meta-analysis by Szajewska et al. found that Lactobacillus rhamnosus GG (LGG: a well-studied probiotic bacterial strain with documented evidence for shortening acute infectious diarrhea in children) reduced the duration of acute diarrhea by an average of 0.9–1.1 days [1]. Saccharomyces boulardii is also supported by multiple RCTs. The 2014 ESPGHAN/ESPID guidelines conditionally recommend probiotic use for acute gastroenteritis [3]. The AAP (American Academy of Pediatrics) offered qualified support for probiotics in acute diarrhea in a 2010 statement [3].
Where the Evidence Is Weak
For constipation, allergy prevention, and upper respiratory tract infections, consistency across trials is poor. The current evidence base is insufficient to support recommendations for any of those indications. The widespread framing around "improving the gut environment" sounds plausible, but it should not be conflated with demonstrated efficacy for specific symptoms from specific strains.
What to Watch For
Probiotic products vary enormously in strain identity and colony count. A label saying "contains live cultures" or "with lactobacillus" does not establish efficacy. Additionally, administering live organisms to an immunocompromised child carries a small risk of sepsis; this use is specifically not recommended [3].
Vitamin D
Where the Recommendation Is Clearest: Supplementation for Breastfed Infants
Vitamin D is the complementary intervention with the strongest consensus from professional bodies. Both the AAP and the Japanese Society of Pediatrics make specific numerical recommendations.
Human milk typically contains 12–60 IU/L — nowhere near the approximately 400 IU/day an infant needs [4]. Since the Wagner and Greer (2008) AAP statement, the standard recommendation has been: breastfed and predominantly breastfed infants (more than 50% of intake from breast milk) should receive 400 IU/day of vitamin D beginning soon after birth [4]. The Japanese Society of Pediatrics issued a supporting statement in 2021 [6].
Vitamin D-deficiency rickets: a bone-softening disease in children caused by insufficient vitamin D, leading to bowed legs, skeletal deformity, and impaired growth is not a historical disease. Trends toward sun avoidance and exclusive breastfeeding have led to reports of resurgence in Japan and many other countries [6].
Ceiling and Overdose
The Institute of Medicine (IOM) Dietary Reference Intakes set the tolerable upper intake level for infants at 1,000–1,500 IU/day [7]. Many commercially available drops deliver 400 IU per drop, making dose management relatively straightforward — though products vary, so checking the concentration at purchase is essential.
"Sunlight is enough" is not a reliable substitute. UV exposure depends on season, latitude, weather, and time outdoors; none of those can be guaranteed consistent. For households practicing primarily indoor childcare, or using sunscreen regularly, supplementation is the practical approach.
Herbal Medicine (Kampo)
Commonly Used Formulas and the State of the Evidence
Traditional Japanese herbal medicine (Kampo) is widely prescribed in Japanese pediatric practice; a domestic survey found that more than 70% of pediatricians have prescribed Kampo preparations [8]. Here is the evidence picture for three commonly used formulas.
| Formula | Primary indication | RCT evidence | Assessment |
|---|---|---|---|
| Yokukansan | Night crying, nervous irritability | Yes (small-scale) | Limited positive signals |
| Shokenchuto | Constitutional weakness, recurrent abdominal pain | Yes (sparse) | Some evidence for functional pain |
| Goreisan | Vomiting, headache | Yes (sparse) | Reports of benefit in acute gastroenteritis |
A 2012 prospective observational study by Nakai et al. found possible improvement in peripheral symptoms of autism spectrum disorder with yokukansan, but sample size was small and blinding was inadequate, warranting cautious interpretation [9].
"Herbal Does Not Mean Safe"
The critical point about Kampo is that it has side effects. Formulas containing kanzō (licorice root) — including shakuyaku-kanzō-tō and shokenchuto — can cause pseudoaldosteronism: a drug-induced syndrome mimicking excess aldosterone, characterized by low potassium, high blood pressure, and fluid retention (hypokalemia: abnormally low potassium levels in the blood, which can cause muscle weakness, cramps, or cardiac arrhythmia). Interactions with conventional pharmaceuticals have also been reported (warfarin among others). Using these preparations on the assumption that they have no side effects is a mistake [10].
Kampo granule preparations are also designed around adult dosing — dose adjustment for children requires expertise. Kampo use in children should involve a physician or pharmacist with pediatric prescribing experience [10].
Putting It Into Practice
1. Using LGG or S. boulardii as a supportive measure during acute diarrhea is a currently evidence-supported choice. Verify the strain name on the label — "contains probiotics" does not identify the strain.
2. Exclusively or predominantly breastfed infants should receive 400 IU/day of vitamin D starting soon after birth. This is one of the few complementary interventions with clear, quantified recommendations from both AAP and Japanese professional bodies. Liquid drops sold for this purpose handle the dosing.
3. If considering Kampo, do not start from the assumption that it carries no side effects. Consult a physician or pharmacist with pediatric Kampo experience; ask about side effects and interactions with any other medications the child is taking.
Summary
The effectiveness categories are real distinctions. Probiotics for acute diarrhea are supported by multiple meta-analyses; probiotics for constipation or allergy prevention are not, at least not yet. Vitamin D supplementation for breastfed infants has scientific consensus behind it, but overdose is bounded. Kampo is widely prescribed but not free of adverse effects.
When evaluating any complementary therapy, the productive question is not "is it natural?" but "what is the evidence for this specific claim, in this condition, at this dose?"
References
- Szajewska H, Skórka A, Ruszczyński M, Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children — updated analysis of randomised controlled trials. Aliment Pharmacol Ther. 2013;38(5):467–476. PMID: 23841880.
- Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr. 2014;59(1):132–152. PMID: 24739189.
- Thomas DW, Greer FR; American Academy of Pediatrics Committee on Nutrition; Section on Gastroenterology, Hepatology, and Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126(6):1217–1231. PMID: 21115585.
- Wagner CL, Greer FR; American Academy of Pediatrics Section on Breastfeeding; Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122(5):1142–1152. PMID: 18977996.
- Golden NH, Abrams SA; Committee on Nutrition, American Academy of Pediatrics. Optimizing bone health in children and adolescents. Pediatrics. 2014;134(4):e1229–e1243. PMID: 25266429.
- Japanese Society of Pediatrics. Prevention and Treatment of Vitamin D-Deficiency Rickets and Hypocalcemia. J Jpn Pediatr Soc. 2021;125(10):1527–1530.
- Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press; 2011. PMID: 21796828.
- Ogawa K, et al. Survey of Kampo prescription practices in pediatric settings. J Jpn Oriental Med. 2019;70(3):239–246.
- Nakai Y, et al. Efficacy of yokukansan (TJ-54) in treating children with autism spectrum disorders and their caregivers: a prospective open-label study. Phytomedicine. 2012;19(3–4):217–224. PMID: 22178481.
- Pediatric Kampo Medicine Study Group of Japan. Appropriate Use Guide for Pediatric Kampo Extract Preparations, 2nd ed. Pediatric Kampo Medicine Study Group of Japan; 2020.